World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
64
Citations
26738
World Ranking
1700
National Ranking
858

Martin Carroll publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Martin Carroll sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 476 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Martin Carroll D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Martin Carroll sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 64 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Martin Carroll is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on medicine, with significant contributions to biochemistry, genetics, and molecular biology.

The main fields of study for Martin Carroll encompass medicine and biochemistry, genetics, and molecular biology, with notable subfields including hematology, molecular biology, cancer research, oncology, and genetics. Their work notably addresses topics such as acute myeloid leukemia research, cancer genomics and diagnostics, histone deacetylase inhibitors research, protein degradation and inhibitors, acute lymphoblastic leukemia research, myeloproliferative neoplasms diagnosis and treatment, and hematopoietic stem cell transplantation.

Martin Carroll has contributed to several recent papers, including:

  • Single-cell mutation analysis of clonal evolution in myeloid malignancies, 2020, Nature
  • DNA methylation-calling tools for Oxford Nanopore sequencing: a survey and human epigenome-wide evaluation, 2021, Genome Biology
  • Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence, 2021, Cancer Discovery
  • Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging, 2024, Cell
  • Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia, 2021, The Journal of Experimental Medicine

The scientist frequently publishes in notable venues, with the largest body of work appearing in Blood, followed by bioRxiv (Cold Spring Harbor Laboratory), Cancer Research, Cancer Discovery, and Leukemia.

Frequent coauthors collaborating with Martin Carroll include Sarah Skuli, Gerald Wertheim, Sarah K. Tasian, Kathrin M. Bernt, and Christian Hurtz.

Best Publications

  • Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

    Timothy J. Ley;Christopher Miller;Li Ding;Benjamin J. Raphael

  • The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

    Patrick S. Ward;Jay Patel;David R. Wise;Omar Abdel-Wahab

  • The N 6 -methyladenosine (m 6 A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells

    Ly P Vu;Brian F Pickering;Yuanming Cheng;Sara Zaccara

  • Chemotherapy Resistant Human Acute Myeloid Leukemia Cells are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

    Thomas Farge;Thomas Farge;Estelle saland;Estelle saland;Fabienne de Toni;Fabienne de Toni;Nesrine Aroua;Nesrine Aroua

  • ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.

    Omar Abdel-Wahab;Mazhar Adli;Lindsay M. LaFave;Jie Gao

  • Survival of acute myeloid leukemia cells requires PI3 kinase activation

    Qing Xu;Serge Emile Simpson;Timothy J. Scialla;Adam Bagg

  • Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells

    Saar Gill;Sarah K. Tasian;Marco Ruella;Olga Shestova

  • An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

    Monica L. Guzman;Randall M. Rossi;Sundar Neelakantan;Xiaojie Li

  • Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

    Jean-Emmanuel Sarry;Kathleen Murphy;Robin Perry;Patricia V. Sanchez

  • AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3

    Wunderlich M;Chou Fs;Link Ka;Mizukawa B

  • The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways

    M Carroll;M H Tomasson;G F Barker;T R Golub

  • Single-cell mutation analysis of clonal evolution in myeloid malignancies.

    Linde A. Miles;Robert L. Bowman;Tiffany R. Merlinsky;Isabelle S. Csete

  • Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia

    Sheng Li;Francine E Garrett-Bakelman;Stephen S Chung;Mathijs A Sanders

  • Distinct IL-2 Receptor Signaling Pattern in CD4+CD25 + Regulatory T Cells

    Steven J. Bensinger;Patrick T. Walsh;Jidong Zhang;Martin Carroll

  • Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR

    Stella Maris Ranuncolo;Jose M Polo;Jamil Dierov;Michael Singer

  • Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

    Elizabeth O. Hexner;Cynthia Serdikoff;Mahfuza Jan;Cezary R. Swider

  • Tribbles homolog 2 inactivates C/EBPα and causes acute myelogenous leukemia

    Karen Keeshan;Yiping He;Bas J. Wouters;Olga Shestova

  • Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data

    Duane C. Hassane;Monica L. Guzman;Cheryl Corbett;Xiaojie Li

  • Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia.

    Courtney D. DiNardo;Kathleen J. Propert;Alison W. Loren;Elisabeth Paietta

  • mTOR regulates cell survival after etoposide treatment in primary AML cells.

    Unknown

Frequent Co-Authors

David L. Porter
David L. Porter University of Pennsylvania
Ari Melnick
Ari Melnick Cornell University
Ross L. Levine
Ross L. Levine Memorial Sloan Kettering Cancer Center
Adam Bagg
Adam Bagg Hospital of the University of Pennsylvania
Stephan A. Grupp
Stephan A. Grupp Children's Hospital of Philadelphia
Edward A. Stadtmauer
Edward A. Stadtmauer University of Pennsylvania
Christopher E. Mason
Christopher E. Mason Cornell University
Christian Recher
Christian Recher Federal University of Toulouse Midi-Pyrénées
David T. Teachey
David T. Teachey Children's Hospital of Philadelphia
Martin S. Tallman
Martin S. Tallman Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in studying Molecular Biology or pivoting to healthcare, a range of online degree options and career pathways are available. Many professionals are now leveraging adn to np programs to accelerate their transition from nursing to advanced healthcare careers while building on their science background.

If you do not have a nursing degree but wish to enter the field, there are highly efficient online msn programs for non nurses that provide a direct entry pathway for those with a bachelor’s degree in a science discipline.

Choosing an online program can be challenging, with options like WGU, Chamberlain, and Capella offering accessible RN to BSN tracks. Comparing wgu vs chamberlain can help you identify the best fit based on cost, flexibility, and reputation.

Affordability is a key concern for many prospective students. There are affordable options such as the cheapest bsn to msn online programs, designed to reduce the financial barriers to advanced education and make career advancement more accessible.

Best Scientists Citing Martin Carroll

Trending Scientists

Recently Published Articles